News
The rise of GLP-1 drugs is a reminder that we must move beyond the simple equation of thinness as health and value. These ...
People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea and to ...
On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...
People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
Thrive Health Solutions also faces a lawsuit from drugmaker Eli Lilly, for allegedly making false claims about FDA approval ...
Semaglutide, a popular anti-obesity drug, may come with a hidden cost: significant muscle loss, especially in women and older ...
Among patients receiving semaglutide for obesity management, the risk for muscle loss may be higher in older adults and women ...
Dear J.H.: Metformin, a treatment for diabetes that works mostly by preventing the liver from making sugar, isn't new and has ...
If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...
Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results